González QJ, Rivera ÁS

Language: Spanish
References: 17
Page: 61-68
PDF size: 170.76 Kb.

ABSTRACT

Pyridinoline (ICTP) is a molecule of collagen degradation that after bone resorption and degradation of the collagen matrix is released into the circulation and can not pass anabolic pathways and reused during collagen synthesis, whereby it could be considered a specific biomarker of bone resorption. The aim of this study is to determine the levels of ICTP in the GCF patients with progressive chronic periodontitis. In 14 inactive sites and 14 active sites determined by the method of tolerance, ICTP levels were measured using the ICTP EIA. Uni Q, the results were analyzed using Stata 7.0 program and the student-test for nonparametric samples. It was determined that the levels of ICTP in the active sites were high and the difference inactive sites were statistically significant (p = 0.001). Based in our results we concluded that the high levels of ICTP suggests its use as a predictor of alveolar bone destruction.

REFERENCES

1. Listgarten M. A. Pathogenesis of periodontitis. J. Clin Peridontol 1986; 13: 418-425.

2. Flemmig T. F. Periodontitis. 1999 International Workshop for a Classification of Periodontal Diseases and Conditions. Annals of Periodontol; 4: 35-40.

3. Page R., Offenbaacher S., Schoeder H., Seymour G., Kornman K. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontology 2000 1997; 14: 216-248.

4. Goodson J. M. Diagnosis of periodontitis by Physical measurement interpretation from episodic disease hypothesis. J. Periodontol 1992: 634: 373-378.

5. Taba M., Kinney J., Kim A., Giannobile W. Diagnostic Biomarkers for Oral and Periodontal Diseases. Dent Clin N. Am 2005; 49: 551-71.

6. Biomarkers Definitions Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.

7. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta 2004; 343:1-16.

8. Zambon J. J., Nakamura M., Slots J. Effect of periodontal therapy on salivary enzymatic activity. J. Periodontal Res 1985; 20:652-9.

9. Narayanan A. S., Page R. C. Connective tissues of the periodontium: a summary of current work. Coll Relat Res 1983; 3 (1): 33-64.

10. Eriksen E. F., Charles P., Melsen F., et al. Serum markers of Type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J. Bone Miner Res 1993; 8: 127-132.

11. Giannobile W. V. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction. Ann N. Y Acad Sci 1999: 878: 404-412.

12. Uebelhart D., Gineyts E., Chapuy M. C. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990;8: 87-96.

13. Palys M. D., Haffajee A. D., Socransky S. S., et al. Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis. J. Clin Peridontol 1998; 25:865-71.

14. Haffajee A. D., Socransky S., Goodson J. M. Clinical parameters as predictors of destructive periodontal disease activity. J. Clin Periodontol 1983; 10:257-265.

15. Reinhardt RA1, Stoner J. A., Golub L. M., Lee H. M., Nummikoski P. V., Sorsa T., Payne J. B. Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis. J. Periodontol 2010. Feb81(2): 251-9.

16. Arikan F. L., Buduneli N., Lappin D. F. C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a casecontrol study. Int J. Oral Maxillofac Implants. 2011 Mar-Apr; 26 (2): 282-9.

17. Oringer R. J. L., Palys M. D., Iranmanesh A, Fiorellini J. P., Haffajee A. D., Socransky S. S., Giannobile W. V. C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin Oral Implants Res. 1998 Dec; 9 (6): 365-73.